Market Tracker

01/30 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.61
Data as of Jan 30
 -0.10 / -5.85%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.81%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.71
Today’s open1.68
Day’s range1.61 - 1.73
Volume517,065
Average volume (3 months)1,271,948
Market cap$257.8M
Dividend yield--
Data as of 4:05pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...+0.49+3.27%
SVASinovac Biotech Ltd+0.04+0.84%
CARACara Therapeutics In...-0.15-1.37%
SNTASynta Pharmaceutical...-0.09-3.64%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts